Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebrun

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Psychoneuroendocrinology|January 1, 1984
Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesisM Le Moal, R Dantzer, P Mormède, et al.
Molecular and Cellular Neurosciences|December 4, 2012
Klf9 is necessary and sufficient for Purkinje cell survival in organotypic cultureC Lebrun, H X Avci, R Wehrlé, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case studyF Berna, F Blanc, C Lebrun, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaC Papeix, J-S Vidal, J de Seze, et al.
NPJ Parkinson'S Disease|March 28, 2018
Rhythmic abilities and musical training in Parkinson's disease: do they help?V Cochen De Cock, D G Dotov, P Ihalainen, et al.
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 16, 2013
Longitudinal follow-up of vision in a neuromyelitis optica cohortM Bouyon, N Collongues, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2020
Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disordersK Bigaut, C Lambert, L Kremer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcomeM C Etienne, J L Formento, C Lebrun-Frenay, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Psychoneuroendocrinology|January 1, 1984
Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesisM Le Moal, R Dantzer, P Mormède, et al.
Molecular and Cellular Neurosciences|December 4, 2012
Klf9 is necessary and sufficient for Purkinje cell survival in organotypic cultureC Lebrun, H X Avci, R Wehrlé, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case studyF Berna, F Blanc, C Lebrun, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaC Papeix, J-S Vidal, J de Seze, et al.
NPJ Parkinson'S Disease|March 28, 2018
Rhythmic abilities and musical training in Parkinson's disease: do they help?V Cochen De Cock, D G Dotov, P Ihalainen, et al.
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 16, 2013
Longitudinal follow-up of vision in a neuromyelitis optica cohortM Bouyon, N Collongues, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2020
Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disordersK Bigaut, C Lambert, L Kremer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcomeM C Etienne, J L Formento, C Lebrun-Frenay, et al.
Pageof 21